SAR650984 (Isatuximab), Lenalidomide, and Dexamethasone in Combination in RRMM Patients

Clinical trial NCT01749969 · COMPLETED

Trial details

NCT number: NCT01749969
Sponsor: Sanofi
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Plasma Cell Myeloma

Start date: 2013-02-06
Primary completion: 2023-06-20
Enrollment: 57

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.